February 5, 2010 — Results from 8 clinical trials show that recombinant human thrombin (rThrombin; Recothrom, ZymoGenetics, Inc) is well tolerated in several surgical settings for topical hemostasis ...
Results suggest research is closer to making recombinant factor VIIa work ...
CHICAGO, IL—A shelf-stable blood product may be a reasonable alternative to frozen plasma in cardiac surgery patients who experience bleeding, the FARES-II trial suggests. The four-factor prothrombin ...
Uncontrolled bleeding during surgery remains one of the deadliest medical emergencies. Injuries to internal organs such as the liver or spleen are especially dangerous because bleeding is difficult to ...